LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Long Term Provisions History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.47 Cr | ₹0.61 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.46 Cr |
What is the latest Long Term Provisions ratio of LASA SUPERGENERICS ?
| Year | Long Term Provisions |
|---|---|
| Mar2024 | ₹0.47 Cr |
| Mar2023 | ₹0.61 Cr |
| Mar2022 | ₹0.63 Cr |
| Mar2021 | ₹0.59 Cr |
| Mar2020 | ₹0.46 Cr |
How is Long Term Provisions of LASA SUPERGENERICS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.47 Cr | -21.78 | |
| Mar2023 | ₹0.61 Cr | -3.19 | |
| Mar2022 | ₹0.63 Cr | 6.83 | |
| Mar2021 | ₹0.59 Cr | 26.84 | |
| Mar2020 | ₹0.46 Cr | - | |
Compare Long Term Provisions of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹39.4 Cr | -3.3% | -14% | -63.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -3.3% |
-14% |
-63.4% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses